Opus Genetics, Inc. (IRD) Balance Sheet
As of 2026-06-30 (10-Q), Opus Genetics, Inc. (IRD) reported total assets of $93.0M, total liabilities of $106.0M and shareholders' equity of -$13.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $88.8M. Long-term debt: $35.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IRDOpus Genetics, Inc.Follow IRD — free
—
Price chart with a free account
- Market cap
- 288.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9.9 | 13.5 | 18.7 | 9.8 | 10.2 | 11.6 | 8.9 | 8.7 | 1.5 | 16.4 | 24.5 | 42.6 | 50.5 | 30.3 | 45.1 | 88.8 | |
| Short-term investments | 2.0 | 0.1 | 0.1 | 22.9 | 13.2 | 8.7 | 17.9 | 6.0 | 3.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Receivables | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 1.3 | 0.9 | 3.6 | 2.0 | 1.0 | |
| Current assets | 12.2 | 13.8 | 19.3 | 33.4 | 24.7 | 20.9 | 28.1 | 15.9 | 1.8 | 17.7 | 26.1 | 49.0 | 53.9 | 36.6 | 50.0 | 92.7 | |
| Total assets | 13.7 | 14.9 | 19.6 | 33.5 | 24.8 | 21.0 | 28.3 | 16.0 | 1.8 | 17.7 | 26.1 | 49.0 | 53.9 | 36.9 | 50.2 | 93.0 | |
| Current liabilities | — | — | — | — | — | — | — | 3.2 | 9.3 | 3.2 | 3.9 | 2.8 | 4.0 | 11.3 | 7.8 | 7.6 | |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 1.1 | 35.3 | |
| Short-term debt | — | — | — | — | — | — | — | — | 5.0 | 0.0 | 0.5 | 0.0 | — | — | — | — | |
| Total liabilities | 3.0 | 5.4 | 6.9 | 7.0 | 6.0 | 4.0 | 11.5 | 5.5 | 9.3 | 31.1 | 3.9 | 2.8 | 4.0 | 11.3 | 34.9 | 106.0 | |
| Shareholders' equity | 10.7 | 9.5 | 12.6 | 26.6 | 18.8 | 17.1 | 16.8 | -1.7 | -7.6 | -13.5 | 22.2 | 46.2 | 49.9 | 6.7 | 15.3 | -13.0 |
USD millions · SEC XBRL
Opus Genetics, Inc. — questions
- How much cash does Opus Genetics, Inc. have?
- $88.8M in cash and cash equivalents as of 2026-06-30.
- How much debt does Opus Genetics, Inc. have?
- $35.3M of long-term debt as of 2026-06-30.
- What are Opus Genetics, Inc.'s total assets?
- $93.0M as of 2026-06-30.
- What is Opus Genetics, Inc.'s shareholders' equity?
- -$13.0M as of 2026-06-30.
Every figure on this page comes from Opus Genetics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.